• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    60 Biggest Movers From Yesterday

    1/11/22 4:52:58 AM ET
    $AACG
    $ADMP
    $APR
    $APYX
    Other Consumer Services
    Real Estate
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AACG alert in real time by email

    Gainers

    • Bone Biologics Corporation (NASDAQ:BBLG) shares surged 57.1% to close at $5.39 on Monday.
    • Zynga Inc. (NASDAQ:ZNGA) rose 40.7% to settle at $8.44 after the company announced it will be acquired by Take-Two Interactive Software in a cash and stock transaction valued at $9.86 per Zynga share, representing a total enterprise value of approximately $12.7 billion.
    • Molecular Partners AG (NASDAQ:MOLN) surged 30.5% to settle at $21.50 after the company, and Novartis, reported topline data from the Phase 2 study for ensovibep, a DARPin antiviral therapeutic for COVID-19.
    • Reliance Global Group, Inc. (NASDAQ:RELI) climbed 28.9% to close at $7.86. Reliance Global Group, last month, announced pricing of $20.0 million private placement with institutional investors.
    • RxSight, Inc. (NASDAQ:RXST) gained 28.2% to settle at $11.50 after the company late Sunday issued preliminary Q4 and FY21 guidance above estimates.
    • BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) jumped 27.9% to close at $14.78 after the company announced preliminary, unaudited ORLADEYO revenue for Q4 and FY21 and provided new guidance for full year 2022 ORLADEYO net revenue and expected peak ORLADEYO sales.
    • iRhythm Technologies, Inc. (NASDAQ:IRTC) surged 27.6% to settle at $130.04.
    • Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) rose 27% to close at $0.73 after the company announced the submission of a Fast Track Application to the FDA for Tempol for the treatment and prevention of COVID-19.
    • Apria, Inc. (NASDAQ:APR) shares gained 26.1% to close at $37.48. Owens & Minor agreed to acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion.
    • Discovery, Inc. (NASDAQ:DISCB) climbed 25.5% to close at $44.50. The company, along with AT&T, recently won a favorable ruling from the Internal Revenue Service for the planned merger between the company and AT&T's WarnerMedia entertainment business.
    • Pluristem Therapeutics Inc. (NASDAQ:PSTI) jumped 24.5% to close at $1.83. Pluristem Therapeutics and Tnuva Group have collaborated to develop, manufacture and commercialize cultured cell-based products for the food industry.
    • Olink Holding AB (NASDAQ:OLK) rose 23.8% to settle at $14.46. Olink said it sees Q4 sales of $43.2 million to $43.7 million and expects FY21 sales of $94.5 million to $95 million.
    • Biofrontera Inc. (NASDAQ:BFRI) gained 22% to close at $6.26.
    • Immunic, Inc. (NASDAQ:IMUX) jumped 19.2% to settle at $11.49.
    • Apyx Medical Corporation (NASDAQ:APYX) shares rose 19.1% to settle at $12.98. Apyx Medical Corporation sees preliminary Q4 sales of $16.3 million to $16.8 million, up 42% year over year.
    • CareDx, Inc (NASDAQ:CDNA) shares jumped 18.5% to close at $46.29 after the company issued strong sales forecast.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) jumped 17.3% to close at $2.64. McDade Products, LLC joined forces with G Medical Tests and Services to provide U.S. retailers with millions of COVID-19 at-home PCR test kits.
    • Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) gained 16.8% to settle at $2.50.
    • Lucira Health, Inc. (NASDAQ:LHDX) rose 15.6% to close at $8.29 after the company issued strong sales forecast for the fourth quarter.
    • Treace Medical Concepts, Inc. (NASDAQ:TMCI) gained 14.9% to close at $20.25. Treace Medical Concepts sees Q4 sales of $33.100 million to $33.400 million.
    • Odonate Therapeutics, Inc. (NASDAQ:ODT) surged 14.7% to settle at $1.25. Odonate Therapeutics recently received notice from The Nasdaq Stock Market that the continued listing of its securities is no longer warranted.
    • Century Therapeutics, Inc. (NASDAQ:IPSC) gained 14.5% to close at $15.14. Century Therapeutics and Bristol Myers Squibb have announced a research collaboration and license agreement for up to four induced pluripotent stem cell (iPSC) programs for hematologic malignancies and solid tumors.
    • Venus Concept Inc. (NASDAQ:VERO) jumped 13.8% to settle at $1.82. Venus Concept sees Q4 sales of $32 million to $33 million.
    • Tilray, Inc. (NASDAQ:TLRY) gained 13.6% to close at $7.29 after the company announced fiscal second-quarter 2022 financial results showing revenue increased year-over-year and the company reached profitability.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) rose 12.7% to close at $6.02.
    • Arco Platform Limited (NASDAQ:ARCE) shares gained 10.1% to settle at $20.55.
    • Jazz Pharmaceuticals plc (NASDAQ:JAZZ) jumped 9% to settle at $146.49 after the company announced its Vision 2025 expectations.

     

    Check out these big penny stock gainers and losers

    Losers

    • TDH Holdings, Inc. (NASDAQ:PETZ) shares tumbled 81.9% to close at $0.74 on Monday. TDH Holdings, last month, reported H1 revenue of $130,000.
    • OneSmart International Education Group Limited (NYSE:ONE) fell 33.1% to close at $0.1941 after gaining more than 5% on Friday.
    • Kidpik Corp. (NASDAQ:PIK) fell 27.5% to settle at $4.75. Kidpik, last month, posted a Q3 loss of $0.22 per share.
    • Torrid Holdings Inc. (NYSE:CURV) fell 22.4% to close at $8.20 after the company lowered its Q4 revenue guidance.
    • Rapid Micro Biosystems, Inc. (NASDAQ:RPID) fell 21.2% to close at $7.20. Rapid Micro Biosystems said it expects Q4 total revenue of between $4.7 and $5.2 million.
    • China HGS Real Estate Inc. (NASDAQ:HGSH) fell 21% to close at $2.75 after jumping over 57% on Friday.
    • Marin Software Incorporated (NASDAQ:MRIN) dipped 19% to close at $3.67. Marin Software shares jumped 31% on Friday after the company announced an integration with Amazon Ads' demand-side platform.
    • eMagin Corporation (NYSE:EMAN) fell 18.9% to settle at $1.46.
    • Elite Education Group International Limited (NASDAQ:EEIQ) tumbled 18.4% to close at $2.40.
    • Bird Global, Inc. (NYSE:BRDS) fell 17.6% to close at $6.81.
    • Excellon Resources Inc. (NYSE:EXN) dropped 17.5% to settle at $0.7706.
    • Marpai, Inc. (NASDAQ:MRAI) shares dropped 17.2% to close at $2.92.
    • Amicus Therapeutics, Inc. (NASDAQ:FOLD) fell 17.2% to close at $9.45. Amicus Therapeutics said it sees FY21 Galafold sales of $306 million.
    • ATA Creativity Global (NASDAQ:AACG) fell 17.1% to settle at $2.19 after jumping more than 33% on Friday.
    • The Beauty Health Company (NASDAQ:SKIN) dropped 16.7% to close at $18.46. Beauty Health expects FY21 sales around the high end of prior guidance of $245 million to $255 million.
    • Pixelworks, Inc. (NASDAQ:PXLW) fell 16.6% to close at $3.43.
    • Citi Trends, Inc. (NASDAQ:CTRN) shares fell 16.3% to close at $67.89. Citi Trends reported 2021 holiday sales results and updated long-term strategic plan.
    • Nurix Therapeutics, Inc. (NASDAQ:NRIX) tumbled 15.9% to close at $23.27.
    • RAPT Therapeutics, Inc. (NASDAQ:RAPT) dropped 15.8% to settle at $32.89.
    • Energy Focus, Inc. (NASDAQ:EFOI) fell 15.7% to settle at $2.89.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) dropped 15.2% to close at $1.96.
    • Hour Loop, Inc. (NASDAQ:HOUR) declined 14.8% to close at $6.81. The company’s stock jumped around 100% on Friday after the company priced its IPO at $4 per share.
    • Eliem Therapeutics, Inc. (NASDAQ:ELYM) shares fell 14.7% to close at $9.43.
    • Take-Two Interactive Software, Inc. (NASDAQ:TTWO) dropped 13.1% to close at $142.99 after the company announced it will acquire all of the outstanding shares of Zynga in a cash and stock transaction valued at $9.861 per Zynga share, with a total enterprise value of approximately $12.7 billion.
    • Team, Inc. (NYSE:TISI) fell 12.8% to close at $1.02.
    • Zhangmen Education Inc. (NYSE:ZME) fell 12.5% to close at $1.88.
    • CinCor Pharma, Inc. (NASDAQ:CINC) fell 11.7% to settle at $14.13. The company, on Friday, priced its IPO at $16 per share.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) fell 11.1% to close at $1.85.
    • Cyngn Inc. (NASDAQ:CYN) fell 10.5% to close at $3.25. Cyngn said Global Logistics and Fulfillment LLC has engaged the company as its exclusive autonomous vehicle solutions provider.
    • Vigil Neuroscience, Inc. (NASDAQ:VIGL) fell 9.8% to settle at $11.41. The company, on Friday, priced its IPO at $14 per share.
    • Arcadia Biosciences, Inc. (NASDAQ:RKDA) shares fell 7.9% to settle at $1.05 after climbing around 12% on Friday.
    • GameStop Corp. (NYSE:GME) dropped 6.7% to close at $131.15 amid overall market weakness following a rise in yields as well as continued Fed tapering concerns for 2022.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) fell 6.1% to close at $0.3493. FangDD, on Friday, received Nasdaq notice regarding minimum bid requirements.
    Get the next $AACG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AACG
    $ADMP
    $APR
    $APYX

    CompanyDatePrice TargetRatingAnalyst
    RxSight Inc.
    $RXST
    1/30/2026Mkt Perform
    William Blair
    Tilray Brands Inc.
    $TLRY
    1/27/2026Hold
    Canaccord Genuity
    Amicus Therapeutics Inc.
    $FOLD
    1/22/2026$14.50Buy → Hold
    Jefferies
    RAPT Therapeutics Inc.
    $RAPT
    1/9/2026$95.00Overweight
    Piper Sandler
    Nurix Therapeutics Inc.
    $NRIX
    1/8/2026$36.00Equal-Weight → Overweight
    Morgan Stanley
    CareDx Inc.
    $CDNA
    1/6/2026$26.00Buy → Hold
    Craig Hallum
    iRhythm Holdings Inc.
    $IRTC
    1/5/2026$210.00In-line → Outperform
    Evercore ISI
    Amicus Therapeutics Inc.
    $FOLD
    12/29/2025$14.50Outperform → Market Perform
    Leerink Partners
    More analyst ratings

    $AACG
    $ADMP
    $APR
    $APYX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

    SAN FRANCISCO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2025 after the close of trading on Thursday, February 19, 2026. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the conference call on the "Quarterly Results" section of the company's investor website at investors.irhythmtech.com. About iRhythm Holdings, Inc. iRhythm is

    2/5/26 4:30:00 PM ET
    $IRTC
    Medical/Dental Instruments
    Health Care

    Pixelworks Appoints Sevan Brown to Lead Business Development for TrueCut Motion

    20-Year Media and Entertainment Executive to Drive Expanded Partnerships and Industry Adoption of TrueCut Motion™ Platform LOS ANGELES, Feb. 5, 2026 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ:PXLW) ("Pixelworks" or the "Company"), a provider of innovative cinematic and enhanced visualization solutions, today announced the appointment of Sevan Brown as Executive Vice President of Business Development. In the newly created role, Brown will lead the Company's enhanced focus on securing and growing global business partnerships for its TrueCut Motion platform with major Hollywood studios, international exhibitors and streaming service providers. Most recently, Brown served as Senior Vice President

    2/5/26 8:00:00 AM ET
    $PXLW
    Semiconductors
    Technology

    Cyngn Advances Site-Wide Autonomy With DriveMod Tugger Operations Across Connected Facilities

    MOUNTAIN VIEW, Calif., Feb. 5, 2026 /PRNewswire/ -- Cyngn Inc. (NASDAQ:CYN) today highlighted continued expansion of DriveMod Tugger deployments across large, connected industrial facilities, reflecting growing customer demand for site-wide autonomy that supports end-to-end material movement. DriveMod is increasingly being used in workflows that span multiple buildings and outdoor transit corridors, helping organizations reduce bottlenecks, improve throughput consistency, and redeploy labor toward higher-value operations. As warehouses and manufacturing campuses grow larger—of

    2/5/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    $AACG
    $ADMP
    $APR
    $APYX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Director Attal Alain bought $259,577 worth of shares (12,000 units at $21.63), increasing direct ownership by 2% to 596,464 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/21/26 6:32:09 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $AACG
    $ADMP
    $APR
    $APYX
    SEC Filings

    View All

    SEC Form S-8 POS filed by Venus Concept Inc.

    S-8 POS - Venus Concept Inc. (0001409269) (Filer)

    2/6/26 4:47:21 PM ET
    $VERO
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 POS filed by Venus Concept Inc.

    S-8 POS - Venus Concept Inc. (0001409269) (Filer)

    2/6/26 4:47:21 PM ET
    $VERO
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 POS filed by Venus Concept Inc.

    S-8 POS - Venus Concept Inc. (0001409269) (Filer)

    2/6/26 4:47:21 PM ET
    $VERO
    Medical/Dental Instruments
    Health Care

    $AACG
    $ADMP
    $APR
    $APYX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Longitude Capital Partners Ii, Llc sold $190,091 worth of shares (49,000 units at $3.88) (SEC Form 4)

    4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)

    2/6/26 4:26:26 PM ET
    $RPID
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SVP Finance & Operations Carr Douglas sold $589 worth of shares (323 units at $1.82), decreasing direct ownership by 0.06% to 514,551 units (SEC Form 4)

    4 - Century Therapeutics, Inc. (0001850119) (Issuer)

    2/5/26 4:14:34 PM ET
    $IPSC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Operating Officer Kennedy Keith was granted 74,474 shares and covered exercise/tax liability with 4,644 shares, increasing direct ownership by 50% to 209,139 units (SEC Form 4)

    4 - CareDx, Inc. (0001217234) (Issuer)

    2/4/26 4:24:52 PM ET
    $CDNA
    Medical Specialities
    Health Care

    $AACG
    $ADMP
    $APR
    $APYX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZIMHI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug ZIMHI (ORIG-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 212854, Application Classification: Type 5 - New Formulation or New Manufacturer

    10/18/21 11:55:40 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 12, 2021 - FDA Grants First of its Kind Indication for Chronic Sleep Disorder Treatment

    For Immediate Release: August 12, 2021 The U.S. Food and Drug Administration today approved a new indication for Xywav for idiopathic hypersomnia (IH) in adults. IH is an uncommon chronic sleep disorder that causes people to be excessively sleepy during the day even after a good night's sleep. Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution is already approved for the treatment of catapl

    8/12/21 4:25:43 PM ET
    $JAZZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SYMJEPI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug SYMJEPI (SUPPL-12) with active ingredient EPINEPHRINE has changed to 'Approval' on 06/29/2021. Application Category: NDA, Application Number: 207534, Application Classification: Labeling

    6/30/21 5:11:48 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AACG
    $ADMP
    $APR
    $APYX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on RxSight

    William Blair initiated coverage of RxSight with a rating of Mkt Perform

    1/30/26 7:00:55 AM ET
    $RXST
    Ophthalmic Goods
    Health Care

    Canaccord Genuity initiated coverage on Tilray

    Canaccord Genuity initiated coverage of Tilray with a rating of Hold

    1/27/26 9:29:20 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Amicus Therapeutics downgraded by Jefferies with a new price target

    Jefferies downgraded Amicus Therapeutics from Buy to Hold and set a new price target of $14.50

    1/22/26 8:24:52 AM ET
    $FOLD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AACG
    $ADMP
    $APR
    $APYX
    Leadership Updates

    Live Leadership Updates

    View All

    Pixelworks Appoints Sevan Brown to Lead Business Development for TrueCut Motion

    20-Year Media and Entertainment Executive to Drive Expanded Partnerships and Industry Adoption of TrueCut Motion™ Platform LOS ANGELES, Feb. 5, 2026 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ:PXLW) ("Pixelworks" or the "Company"), a provider of innovative cinematic and enhanced visualization solutions, today announced the appointment of Sevan Brown as Executive Vice President of Business Development. In the newly created role, Brown will lead the Company's enhanced focus on securing and growing global business partnerships for its TrueCut Motion platform with major Hollywood studios, international exhibitors and streaming service providers. Most recently, Brown served as Senior Vice President

    2/5/26 8:00:00 AM ET
    $PXLW
    Semiconductors
    Technology

    Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois

    BRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), has announced appointment of Romano Beverage, a respected partner, to manage distribution responsibilities within the state. Romano Beverage, a trusted leader in beverage distribution, is now overseeing Breckenridge Distillery's full spirits collection across Illinois—including its celebrated bourbon whiskey, whiskey, rum, vodka, gin, and newly launched Mountain Shot. Romano's strong presence in Illinois and dedication to exceptional service make them the perfect partner to help Breckenridge Distillery thr

    2/4/26 8:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

    TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With

    1/27/26 8:23:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $AACG
    $ADMP
    $APR
    $APYX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    SEC Form SC 13G filed by Torrid Holdings Inc.

    SC 13G - Torrid Holdings Inc. (0001792781) (Subject)

    12/12/24 6:06:52 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $AACG
    $ADMP
    $APR
    $APYX
    Financials

    Live finance-specific insights

    View All

    iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

    SAN FRANCISCO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2025 after the close of trading on Thursday, February 19, 2026. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the conference call on the "Quarterly Results" section of the company's investor website at investors.irhythmtech.com. About iRhythm Holdings, Inc. iRhythm is

    2/5/26 4:30:00 PM ET
    $IRTC
    Medical/Dental Instruments
    Health Care

    BioCryst to Report Fourth Quarter 2025 Financial Results on February 26

    RESEARCH TRIANGLE PARK, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its fourth quarter 2025 financial results on Thursday, February 26, 2026. BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a corporate update. The live call may be accessed by dialing 1-844-481-2942 for domestic callers and 1-412-317-1866 for international callers. A live webcast and replay of the call will be available online in the investors section of the company website at www.biocryst.com. About BioCryst Pharmaceuticals BioCryst is a global biotechn

    2/5/26 7:01:00 AM ET
    $BCRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Take-Two Interactive Software, Inc. Reports Results for Fiscal Third Quarter 2026

    Company raises fiscal year 2026 outlook Fiscal third quarter Net Bookings were $1.76 billion, above Company's guidance range Net Bookings for fiscal year 2026 are now expected to range from $6.65 to $6.7 billion Take-Two Interactive Software, Inc. (NASDAQ:TTWO) today reported results for the third quarter of its fiscal year 2026, ended December 31, 2025. For further information, please see the third quarter fiscal 2026 results slide deck posted to the Company's investor relations website at take2games.com/ir. CEO Comments Strauss Zelnick, Chairman and CEO of Take-Two Interactive, stated: "Our outstanding third quarter results reflect outperformance from all of our labels, and we a

    2/3/26 4:05:00 PM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AACG
    $ADMP
    $APR
    $APYX
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care